These benefits, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the principle of targeting ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Issues. In response to this situation, the https://cassm948wac3.wikicarrier.com/user